Volitionrx (VNRX) Accumulated Expenses (2018 - 2025)

Volitionrx has reported Accumulated Expenses for 8 years, with the latest figure at $4.2 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 21.14% year-over-year to $4.2 million; the trailing twelve-month figure through Dec 2025 stood at $4.2 million (up 21.14% YoY), and the FY2025 full-year result was $4.2 million, up 21.14% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $4.2 million, down from $4.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $4.6 million in Q3 2025, with the low at $2.7 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $3.5 million across 5 years, with a median of $3.5 million in 2024.
• Annual changes were most pronounced in 2022 — Accumulated Expenses declined 24.98% — and 2023, when it soared 36.78%.
• Volitionrx's Accumulated Expenses stood at $3.8 million in 2021, then dropped by 24.98% to $2.9 million in 2022, then surged by 36.78% to $3.9 million in 2023, then decreased by 11.5% to $3.5 million in 2024, then grew by 21.14% to $4.2 million in 2025.
• The last three Accumulated Expenses figures came in at $4.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.